24/7 Wall Street
26 Oct 2026, 12:45 UTC · 1h ago
2 Safe S&P 500 Dividend Stocks Boomers Can Buy and Hold Forever
Impact · against what's priced in
The article provides no new catalysts for JNJ or PG, as its primary points regarding revenue milestones, oncology growth, and litigation risks are already reflected in current valuations. PG remains pressured by commodity headwinds, while JNJ's valuation continues to hinge on whether it can accelerate growth beyond its current pace.
- JNJ+0.00
Already priced in
- The price assumes
The raised 2026 revenue guidance of $100.3–$101.3 billion
The article notes J&J is on track to exceed $100 billion in annual revenue, a milestone the market has already absorbed into the current price.
What JNJ's price assumes · Sep 3
